SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Cel-Sci Corp (AMEX:CVM) (was HIV) -- Ignore unavailable to you. Want to Upgrade?


To: SKARLOEY who wrote (2201)11/10/1998 6:52:00 PM
From: Tom Shutters  Read Replies (1) | Respond to of 2836
 
"Outpatient IL-2 therapy improves CD4 cell count and immune repertoire"

..."Dr. Carr's group therefore suggests that "IL-2 therapy may serve best...to preserve the immune repertoire rather than to restore lost immunity."...

ama-assn.org

Vaccine coctails begin to gain popularity. It is my opinion that HGP-30 will end up being used in a coctail like the one mentioned in this article.

theaustralian.com.au

Tom